1. Home
  2. RPRX vs RBRK Comparison

RPRX vs RBRK Comparison

Compare RPRX & RBRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • RBRK
  • Stock Information
  • Founded
  • RPRX 1996
  • RBRK 2013
  • Country
  • RPRX United States
  • RBRK United States
  • Employees
  • RPRX N/A
  • RBRK N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • RBRK
  • Sector
  • RPRX Health Care
  • RBRK
  • Exchange
  • RPRX Nasdaq
  • RBRK NYSE
  • Market Cap
  • RPRX 14.2B
  • RBRK 11.9B
  • IPO Year
  • RPRX 2020
  • RBRK 2024
  • Fundamental
  • Price
  • RPRX $32.20
  • RBRK $69.79
  • Analyst Decision
  • RPRX Strong Buy
  • RBRK Strong Buy
  • Analyst Count
  • RPRX 4
  • RBRK 20
  • Target Price
  • RPRX $42.50
  • RBRK $70.56
  • AVG Volume (30 Days)
  • RPRX 4.5M
  • RBRK 2.8M
  • Earning Date
  • RPRX 05-08-2025
  • RBRK 06-10-2025
  • Dividend Yield
  • RPRX 2.73%
  • RBRK N/A
  • EPS Growth
  • RPRX N/A
  • RBRK N/A
  • EPS
  • RPRX 1.91
  • RBRK N/A
  • Revenue
  • RPRX $2,263,576,000.00
  • RBRK $886,544,000.00
  • Revenue This Year
  • RPRX $31.56
  • RBRK $33.44
  • Revenue Next Year
  • RPRX $5.94
  • RBRK $24.85
  • P/E Ratio
  • RPRX $16.84
  • RBRK N/A
  • Revenue Growth
  • RPRX N/A
  • RBRK 41.19
  • 52 Week Low
  • RPRX $24.05
  • RBRK $28.34
  • 52 Week High
  • RPRX $34.20
  • RBRK $80.00
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 51.13
  • RBRK N/A
  • Support Level
  • RPRX $31.58
  • RBRK N/A
  • Resistance Level
  • RPRX $32.73
  • RBRK N/A
  • Average True Range (ATR)
  • RPRX 0.93
  • RBRK 0.00
  • MACD
  • RPRX 0.06
  • RBRK 0.00
  • Stochastic Oscillator
  • RPRX 82.74
  • RBRK 0.00

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About RBRK RUBRIK INC

Rubrik Inc is a company that offers data security solutions to organizations ranging from the largest companies worldwide to mid-sized smaller customers. Its platform is architected to help organizations achieve cyber resilience, which encompasses cyber posture and cyber recovery. They enable organizations to confidently accelerate digital transformation and leverage the cloud to realize business agility.

Share on Social Networks: